166 related articles for article (PubMed ID: 24253178)
21. Identification of ADP-ribosylation factor 4 as a suppressor of N-(4-hydroxyphenyl)retinamide-induced cell death.
Woo IS; Eun SY; Jang HS; Kang ES; Kim GH; Kim HJ; Lee JH; Chang KC; Kim JH; Han CW; Seo HG
Cancer Lett; 2009 Apr; 276(1):53-60. PubMed ID: 19041174
[TBL] [Abstract][Full Text] [Related]
22. ROS-driven Akt dephosphorylation at Ser-473 is involved in 4-HPR-mediated apoptosis in NB4 cells.
Cao J; Xu D; Wang D; Wu R; Zhang L; Zhu H; He Q; Yang B
Free Radic Biol Med; 2009 Sep; 47(5):536-47. PubMed ID: 19482076
[TBL] [Abstract][Full Text] [Related]
23. Effector mechanisms of fenretinide-induced apoptosis in neuroblastoma.
Lovat PE; Ranalli M; Annichiarrico-Petruzzelli M; Bernassola F; Piacentini M; Malcolm AJ; Pearson AD; Melino G; Redfern CP
Exp Cell Res; 2000 Oct; 260(1):50-60. PubMed ID: 11010810
[TBL] [Abstract][Full Text] [Related]
24. Targeting homeostatic mechanisms of endoplasmic reticulum stress to increase susceptibility of cancer cells to fenretinide-induced apoptosis: the role of stress proteins ERdj5 and ERp57.
Corazzari M; Lovat PE; Armstrong JL; Fimia GM; Hill DS; Birch-Machin M; Redfern CP; Piacentini M
Br J Cancer; 2007 Apr; 96(7):1062-71. PubMed ID: 17353921
[TBL] [Abstract][Full Text] [Related]
25. Contributions of mitogen-activated protein kinase and nuclear factor kappa B to N-(4-hydroxyphenyl)retinamide-induced apoptosis in prostate cancer cells.
Shimada K; Nakamura M; Ishida E; Kishi M; Yonehara S; Konishi N
Mol Carcinog; 2002 Nov; 35(3):127-37. PubMed ID: 12410564
[TBL] [Abstract][Full Text] [Related]
26. Bak: a downstream mediator of fenretinide-induced apoptosis of SH-SY5Y neuroblastoma cells.
Lovat PE; Oliverio S; Corazzari M; Rodolfo C; Ranalli M; Goranov B; Melino G; Redfern CP; Piacentini M
Cancer Res; 2003 Nov; 63(21):7310-3. PubMed ID: 14612528
[TBL] [Abstract][Full Text] [Related]
27. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation.
Ponzoni M; Bocca P; Chiesa V; Decensi A; Pistoia V; Raffaghello L; Rozzo C; Montaldo PG
Cancer Res; 1995 Feb; 55(4):853-61. PubMed ID: 7850799
[TBL] [Abstract][Full Text] [Related]
28. BBC3 mediates fenretinide-induced cell death in neuroblastoma.
Wei JS; Whiteford CC; Cenacchi N; Son CG; Khan J
Oncogene; 2005 Dec; 24(54):7976-83. PubMed ID: 16091745
[TBL] [Abstract][Full Text] [Related]
29. Fenretinide sensitizes multidrug-resistant human neuroblastoma cells to antibody-independent and ch14.18-mediated NK cell cytotoxicity.
Shibina A; Seidel D; Somanchi SS; Lee DA; Stermann A; Maurer BJ; Lode HN; Reynolds CP; Huebener N
J Mol Med (Berl); 2013 Apr; 91(4):459-72. PubMed ID: 23052481
[TBL] [Abstract][Full Text] [Related]
30. Fenretinide induces mitochondrial ROS and inhibits the mitochondrial respiratory chain in neuroblastoma.
Cuperus R; Leen R; Tytgat GA; Caron HN; van Kuilenburg AB
Cell Mol Life Sci; 2010 Mar; 67(5):807-16. PubMed ID: 19941060
[TBL] [Abstract][Full Text] [Related]
31. Fenretinide via NOXA Induction, Enhanced Activity of the BCL-2 Inhibitor Venetoclax in High BCL-2-Expressing Neuroblastoma Preclinical Models.
Nguyen TH; Koneru B; Wei SJ; Chen WH; Makena MR; Urias E; Kang MH; Reynolds CP
Mol Cancer Ther; 2019 Dec; 18(12):2270-2282. PubMed ID: 31484706
[TBL] [Abstract][Full Text] [Related]
32. N-(4-hydroxyphenyl)retinamide-induced apoptosis triggered by reactive oxygen species is mediated by activation of MAPKs in head and neck squamous carcinoma cells.
Kim HJ; Chakravarti N; Oridate N; Choe C; Claret FX; Lotan R
Oncogene; 2006 May; 25(19):2785-94. PubMed ID: 16407847
[TBL] [Abstract][Full Text] [Related]
33. Gangliosides link the acidic sphingomyelinase-mediated induction of ceramide to 12-lipoxygenase-dependent apoptosis of neuroblastoma in response to fenretinide.
Lovat PE; Di Sano F; Corazzari M; Fazi B; Donnorso RP; Pearson AD; Hall AG; Redfern CP; Piacentini M
J Natl Cancer Inst; 2004 Sep; 96(17):1288-99. PubMed ID: 15339967
[TBL] [Abstract][Full Text] [Related]
34. Alterations in expression of specific microRNAs by combination of 4-HPR and EGCG inhibited growth of human malignant neuroblastoma cells.
Chakrabarti M; Khandkar M; Banik NL; Ray SK
Brain Res; 2012 May; 1454():1-13. PubMed ID: 22498172
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of 4-HPR-induced apoptosis in glioma cells: evidences suggesting role of mitochondrial-mediated pathway and endoplasmic reticulum stress.
Tiwari M; Kumar A; Sinha RA; Shrivastava A; Balapure AK; Sharma R; Bajpai VK; Mitra K; Babu S; Godbole MM
Carcinogenesis; 2006 Oct; 27(10):2047-58. PubMed ID: 16675469
[TBL] [Abstract][Full Text] [Related]
36. Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators.
Batra S; Reynolds CP; Maurer BJ
Cancer Res; 2004 Aug; 64(15):5415-24. PubMed ID: 15289350
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of free-radical induction in relation to fenretinide-induced apoptosis of neuroblastoma.
Lovat PE; Ranalli M; Corazzari M; Raffaghello L; Pearson AD; Ponzoni M; Piacentini M; Melino G; Redfern CP
J Cell Biochem; 2003 Jul; 89(4):698-708. PubMed ID: 12858336
[TBL] [Abstract][Full Text] [Related]
38. Ceramide signaling in fenretinide-induced endothelial cell apoptosis.
Erdreich-Epstein A; Tran LB; Bowman NN; Wang H; Cabot MC; Durden DL; Vlckova J; Reynolds CP; Stins MF; Groshen S; Millard M
J Biol Chem; 2002 Dec; 277(51):49531-7. PubMed ID: 12388538
[TBL] [Abstract][Full Text] [Related]
39. [Mechanisms of fenretinide-triggered apoptosis in leukemic cells].
Xiao DK; Du YZ; Fan HY; Chen YL; Chen Z; Zhang J; Wang KK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):975-8. PubMed ID: 16403262
[TBL] [Abstract][Full Text] [Related]
40. The chemopreventive agent N-(4-hydroxyphenyl)retinamide induces apoptosis through a mitochondrial pathway regulated by proteins from the Bcl-2 family.
Boya P; Morales MC; Gonzalez-Polo RA; Andreau K; Gourdier I; Perfettini JL; Larochette N; Deniaud A; Baran-Marszak F; Fagard R; Feuillard J; Asumendi A; Raphael M; Pau B; Brenner C; Kroemer G
Oncogene; 2003 Sep; 22(40):6220-30. PubMed ID: 13679861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
